McCusker Trustees meet the new Vice Chancellor of Murdoch University


Dr Rakesh Veedu PhD, McCusker Fellow. Dr Veedu’s McCusker fellowship is developing new treatments for Alzheimers and other neuromuscular diseases by establishing a “smart oligonucleotides synthesis facility”—the first of its kind in Australia capable of developing novel targeted functional nucleic acids. Professor Steve Wilton, Phd, Foundation Chair in Molecular Therapy at Murdoch University, and Director of WANRI, Professor Wilton is currently developing therapeutic applications of antisense oligomers for Duchennes Muscular Dystrophy (in clinical trials in the US) and is developing therapeutic applications to other conditions such as spinal muscular atrophy, cystic fibrosis, multiple sclerosis, Alzheimers, Pompe’s disease, congenital muscular dystrophy, Huntington’s and asthma. Professor Eva Leinonen, Vice Chancellor Murdoch University, appointed in April 2016. Vice Chancellor Leinonen is committed to supporting translational research and promoting research collaboration between Murdoch University and other institutions. Dr David Nolan, Adjunct Professor, Institute for Immunology & Infectious Diseases, Murdoch University, Dr Nolan is leading a team of researchers examining the different risk factors for MS and using these findings to improve diagnosis and development of novel therapeutic strategies for clinical practice. Professor Frank Mastaglia, Deputy Director, Institute for Immunology & Infectious Diseases, Murdoch University. Professor Mastaglia, a neurologist researching neurodegenerative diseases and neurocognitive health is overseeing the establishment of the IIID Academic Medical Centre and is actively engaged in developing mutually beneficial ties between Murdoch University and WA Health organisations.
Category: News